Filing Flows › Precision Biosciences (DTIL) › Recalls, complaints & regulation
Precision Biosciences (DTIL): clinical trials
Precision Biosciences (DTIL) beyond its filings: 3 active clinical trials.
Precision Biosciences' latest quarter
Precision Biosciences, Q3 FY26: revenue $10.8M (374× year over year), operating margin -83.7%, net loss $18.4M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Precision Biosciences have?
3 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.